Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension

Area of Science:

• Cardiovascular Research
• Endocrinology
• Vascular Biology

Background:

• Endothelial mineralocorticoid receptor (eMR) plays a role in endothelial function.
• Sex-specific differences in eMR expression and its link to dysfunction are increasingly recognized.

Purpose of the Study:

• To review recent findings on the endothelial mineralocorticoid receptor's role in endothelial dysfunction and hypertension.
• To explore the clinical potential of targeting the eMR pathway for hypertension treatment.

Main Methods:

• Review of current scientific literature on endothelial mineralocorticoid receptors.
• Analysis of sex-specific expression patterns and signaling pathways.

Main Results:

• Endothelial mineralocorticoid receptor expression is higher in females, influenced by progesterone.
• eMR deletion protects against obesity- and diabetes-associated endothelial dysfunction in female models.
• Intact eMR and progesterone receptor signaling are crucial for obesity-associated endothelial dysfunction in females.
• The signaling pathway involves alpha-epithelial sodium channels (αENaC) in endothelial cells.

Conclusions:

• Sex-specific upregulation of eMR in females, driven by progesterone, is a key mediator of endothelial dysfunction.
• This eMR pathway is implicated in hypertension, especially in obese females.
• The endothelial mineralocorticoid receptor pathway presents a potential target for novel hypertension therapies.